However, ERK inhibitor (PD98059) rather enhanced degradation of XIAP in combination treatment implying that ERK activation can serve a part of cancer cell survival signaling by protecting XIAP from degradation (Supplementary Figure 2C and 2D), while p38 and c-Jun associated signaling is not. This evidence concerns the gene JUN and cancer.